.
Feedback

HP to Slash 27,000 Jobs

Revenue plunge prompts major restructuring.

Palo Alto’s backyard computer giant is reeling after announcing Wednesday a 31 percent drop in second quarter profit to $1.6 billion and three percent drop in revenue, to $30.7 billion.

The news came at the same time as another huge announcement: the company has outlined plans for a “multi-year productivity initiative” designed to “fuel innovation and enable investment,” according to a press release. That plan calls for cutting 27,000 jobs by the end of fiscal year 2014.

The company is offering early retirement to affected workers, and says the exact number of layoffs will be determined by how many employees take that deal.

"These initiatives build upon our recent organizational realignment, and will further streamline our operations, improve our processes, and remove complexity from our business," said Meg Whitman, HP president and chief executive officer, in a statement. "While some of these actions are difficult because they involve the loss of jobs, they are necessary to improve execution and to fund the long term health of the company. We are setting HP on a path to extend our global leadership and deliver the greatest value to customers and shareholders."

HP's losses were led by their Imaging and Printing Group, which includes their consumer hardware products. Consumer hardware revenue was down 15 percent year over year with a 13 decline in printer units.

The company intends to invest the savings from workforce cuts into each of its business segments, with an emphasis on R&D, notably in its core printing and personal systems businesses and in emerging areas, according to the release. Investments will also be made in marketing, sales productivity, tools that make it easier for customers to do business with HP, cloud computing, and information analytics.

HP’s software division will also invest in security, big data and the management of application lifecycle and infrastructure solutions and double down on Autonomy and Vertica.

On the enterprise side, the company will boost R&D investment in servers, storage and networking.

Follow us on Twitter | Like us on Facebook | | Blog for us

Newsletter & Alerts

Get the best stories each day and important breaking news

Subscribe

Not from Pacifica Patch? Find your Local Patch »

Loading comments ...
Note Article
Just a short thought to get the word out quickly about anything in your neighborhood.
Share something with your neighbors. Write a new post... What's up? Make an announcement, speak your mind, or sell something
Janet Arline Barker May 17, 2013 at 11:18 am
Awesome! Next Tuesday, Thursday or Friday are open. Name a time and place. I used to write 3Read More different columns for San Bruno, Millbrae, and Burlingame Patch. I am ready to write for Pacifica Patch & blog too. Here's my personal blog...I do sporadically. Www.art-Janet.blogspot.com My art studio is at Sanchez Art Center #11
Christa Bigue (Editor) May 17, 2013 at 11:05 am
When can we meet for coffee Janet? Since you're the first one to post in our biz update section youRead More get to have coffee and chat with your local Patch editor! Email me at christa.bigue@patch.com and we'll find a date and place.
Anon. April 14, 2013 at 01:43 am
I can start with the comments on the Theravance drug, fluticasone fluroate - the active moiety inRead More this compound is the same, fluticasone (proprionate) that has been marketed by GSK for the same indication for approximately 25 years. Indeed, that patent is so old, and the drug has such a proven track record for safety and efficacy, that the patent has expired and there are generic versions available. There is also in implicit assumption by the author that the only reason that the FDA will approve medications in a short time span is because they are for 'life-or-limb' or unmet serious medical need. This is just not the case - regulators in many countries, including the FDA in the USA, may give accelerated approval to a product, where the safety and tolerability of a product is equivalent to a similar active agent which has already been approved. I suspect this is the case for fluticasone fluroate - but I am not privy to the details of the regulatory filing. I note that none of the companies mentioned here, nor the FDA, has provided input to this article. The journalism in this article smacks of someone trying to make a name for themselves quickly by scaring uneducated and/or anxious people. The science is just plain flawed.
Pacificat April 12, 2013 at 12:49 pm
Please tell us in what ways it is ill-informed
Anon. April 11, 2013 at 08:22 pm
Ill-informed, sensationalist rubbish.
Deb Wong March 26, 2013 at 06:09 pm
Thanks, Stacie!
Stacie Chan (Editor) March 26, 2013 at 02:51 pm
Absolutely stunning photos, Deb! Thanks for sharing. I really feel like I was there by just perusingRead More your photo gallery.
Donna Fentanes March 26, 2013 at 09:49 am
Thanks, Deb, for the videos. Now we all can take one last ride. :)
Jim Clifford March 25, 2013 at 01:08 pm
Each column gets better. I look for "The Shoe."
Deb Wong March 25, 2013 at 11:19 am
I think many of us can relate! 10 kids, huh? I was the oldest of 9, so sort of understand. MyRead More family grew up in Pacifica, & we rode over the slide every weekend when we went to the HMB airport to tend to my father's airplanes. I drove on it once, during driver's ed in high school, scary! I have an old home movie clip from 1966, going over the slide. Very overexposed, but you can still see parts of the slide in it. More recently, took 2 videos of our drive over the slide, North & south views. Going North: http://www.youtube.com/watch?v=Kb8NKnu9Gvw Going South: http://www.youtube.com/watch?v=-rlN_g2LeE8